[1]
|
Flavivirus Cross-Reactivity to Dengue Nonstructural Protein 1 Antigen Detection Assays
Diagnostics,
2019
DOI:10.3390/diagnostics10010011
|
|
|
[2]
|
Blood Safety
2019
DOI:10.1007/978-3-319-94436-4_10
|
|
|
[3]
|
A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus
PLOS ONE,
2019
DOI:10.1371/journal.pone.0212054
|
|
|
[4]
|
Amustaline (S‐303) treatment inactivates high levels of Chikungunya virus in red‐blood‐cell components
Vox Sanguinis,
2018
DOI:10.1111/vox.12626
|
|
|
[5]
|
Amustaline (S-303) treatment inactivates high levels of Chikungunya virus in red-blood-cell components
Vox Sanguinis,
2018
DOI:10.1111/vox.12626
|
|
|
[6]
|
Prevention of transfusion‐transmitted Zika virus in French Polynesia, nucleic acid testing versus pathogen inactivation
ISBT Science Series,
2017
DOI:10.1111/voxs.12335
|
|
|
[7]
|
Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
Transfusion,
2017
DOI:10.1111/trf.14318
|
|
|
[8]
|
Zika Virus and the Blood Supply: What Do We Know?
Transfusion Medicine Reviews,
2017
DOI:10.1016/j.tmrv.2016.08.001
|
|
|
[9]
|
Prevention of transfusion-transmitted Zika virus in French Polynesia, nucleic acid testing versus pathogen inactivation
ISBT Science Series,
2017
DOI:10.1111/voxs.12335
|
|
|
[10]
|
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
Transfusion,
2017
DOI:10.1111/trf.14161
|
|
|
[11]
|
SYBR green-based one step quantitative real-time polymerase chain reaction assay for the detection of Zika virus in field-caught mosquitoes
Parasites & Vectors,
2017
DOI:10.1186/s13071-017-2373-4
|
|
|
[12]
|
Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
Transfusion,
2017
DOI:10.1111/trf.14318
|
|
|
[13]
|
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
Transfusion,
2017
DOI:10.1111/trf.14161
|
|
|
[14]
|
Dengue virus persists and replicates during storage of platelet and red blood cell units
Transfusion,
2016
DOI:10.1111/trf.13454
|
|
|
[15]
|
Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination
Transfusion,
2016
DOI:10.1111/trf.13271
|
|
|
[16]
|
Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination
Transfusion,
2016
DOI:10.1111/trf.13271
|
|
|
[17]
|
Dengue virus persists and replicates during storage of platelet and red blood cell units
Transfusion,
2016
DOI:10.1111/trf.13454
|
|
|
[18]
|
Pathogen Reduction for Platelets
The Korean Journal of Blood Transfusion,
2016
DOI:10.17945/kjbt.2016.27.1.1
|
|
|
[19]
|
Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment
Transfusion,
2015
DOI:10.1111/trf.13030
|
|
|
[20]
|
Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood‐derived therapies
Transfusion,
2015
DOI:10.1111/trf.12933
|
|
|
[21]
|
Pathogen inactivation
Current Opinion in Hematology,
2015
DOI:10.1097/MOH.0000000000000186
|
|
|
[22]
|
Inactivation of viruses in platelet and plasma products using a riboflavin‐and‐UV–based photochemical treatment
Transfusion,
2015
DOI:10.1111/trf.13030
|
|
|
[23]
|
Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non‐leucoreduced platelet‐rich plasma‐derived platelets suspended in plasma
Vox Sanguinis,
2014
DOI:10.1111/vox.12158
|
|
|
[24]
|
Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination
Transfusion,
2014
DOI:10.1111/trf.12713
|
|
|
[25]
|
Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma
Vox Sanguinis,
2014
DOI:10.1111/vox.12158
|
|
|
[26]
|
Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination
Transfusion,
2014
DOI:10.1111/trf.12713
|
|
|